Cipla stock sits 21.42 percent below its 52-week high

Published on 10/14/2026 at 12:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Volume reached 1,103,956 shares on October 14, 2026. Cipla stock stood at INR 1,314.60 on NSE, down 1.13 percent versus the previous close.

Price and dates at a glance

Cipla stock remains 21.42 percent below its 52-week high on October 14, 2026.
Trading volume reached 1,103,956 shares against an average of 1,004,600 shares.
Cipla stock stood at INR 1,314.60 on October 14, 2026 at 3:30 p.m. IST, down 1.13 percent versus the previous close of October 13, 2026.
Cipla traded at a P/E ratio of 31.53 with a market capitalization of INR 1,062.0 billion.

Cipla, INE059A01026, Illustration mit AI erstellt.

Cipla stock (ISIN INE059A01026) stood 21.42 percent below its INR 1,673.00 52-week high on October 14, 2026. The latest NSE quotation was INR 1,314.60 at 3:30 p.m. IST, down 1.13 percent from the previous close of INR 1,329.60 on October 13, 2026.

Volume exceeds its average

Trading volume reached 1,103,956 shares on October 14, 2026, compared with an average volume of 1,004,600 shares. That places activity 9.89 percent above the average, giving the session a clearer participation signal than the price move alone.

The day's range was INR 1,304.10 to INR 1,333.30. The stock therefore finished INR 9.50 above the session low and INR 18.70 below the session high, while remaining inside its established annual range.

Yearly range remains wide

Cipla's 52-week range runs from INR 1,165.70 to INR 1,673.00. The latest price was 12.76 percent above the low and 21.42 percent below the high on October 14, 2026, leaving the share closer to the lower end of its yearly corridor.

The NSE listing is identified as ticker CIPL by Investing.com, which also assigns the company to the Indian market and records ISIN INE059A01026. Cipla operates in specialty and generic pharmaceuticals, with products spanning respiratory, cardiovascular, metabolic and other therapeutic areas.

Valuation and next date

Cipla's market capitalization was INR 1,062.0 billion on October 14, 2026, and its price-to-earnings ratio was 31.53. The dividend yield was 0.01 percent, while the latest quote remained below the annual high despite the company retaining a large listed equity value.

Investing.com lists October 27, 2026 as Cipla's next earnings date. The date gives the market a defined calendar point after the October 14, 2026 session, while the valuation measures provide the current market frame.

Comparison with peers

Cipla (NSE, INR): minus 1.13 percent, P/E 31.53, market capitalization INR 1,062.0 billion
Dr. Reddy's Laboratories (NSE, INR): minus 1.94 percent, P/E 30.62, market capitalization INR 1,012.9 billion
Sun Pharmaceutical Industries (NSE, INR): minus 1.37 percent, P/E 34.64, market capitalization INR 4,190.2 billion

Closing price context

Cipla stood at INR 1,314.60 on October 14, 2026 at 3:30 p.m. IST, down 1.13 percent versus the previous close of October 13, 2026 at INR 1,329.60. The combination of a 21.42 percent gap to the 52-week high and volume 9.89 percent above average places the session in a measurable range without relying on a corporate announcement.